Aplicación YC de Volumetric
Volumetric pasó por Y Combinator en el batch Winter 2020 como una empresa de Healthcare. Abajo: qué hace la empresa, quién la fundó y su aplicación a YC, reconstruida pregunta por pregunta en el formulario real de YC.
- Batch YC
- Winter 2020
- Industria
- HealthcareIndustrial Bio
- Tamaño del equipo
- 5
- Estado
- Acquired
- Lanzado
- 2020
Fundadores
Jordan MillerCo-Founder and President
Bagrat GrigoryanCo-Founder, COO
Lo que hace Volumetric
About Us Volumetric is a recognized world leader in building living multicellular tissues, with a focus on replicating discrete functions of the human body for basic mechanistic biology, laboratory testing and screening, and drug development. Founded in 2018 by Bagrat Grigoryan and Jordan Miller as a spin-out from Rice University, the full potential of our work is to build whole human organ replacements for patients, made from their own cells. Our Technology and Approach We have invented a suite of breakthrough 3D bioprinting technologies, featured on the cover of Science, that can build human tissue with complex blood vessel networks. We are leveraging this technology in the short term to build patient-specific tissues for drug safety and efficacy testing. Patient cells are taken from a biopsy, added to our proprietary 3D printed tissues, and then drug compounds are injected through the blood vessel network to mimic actual drug delivery in humans. Our vision is that our technology will provide rigorous, reproducible, and predictive outcomes for patients, resulting in drastically improved outcomes for diseases like cancer. More broadly, we see the full potential of our mission as being able to produce functional tissue and organ replacements for diseased or damaged vital organs in the body such as the lung, liver, pancreas, kidney, and heart.
Aplicación YC de Volumetric, reconstruida
Solicitud de Y Combinator
Volumetric, batch Winter 2020. Las preguntas reales del formulario, respondidas con datos públicos.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Volumetric
Build living multicellular human tissues
We build living human tissues with complex blood vessel networks using proprietary 3D bioprinting technology. Our product replicates discrete human organ functions for biology research, drug testing, and drug safety screening. We take patient cells from biopsies, add them to printed tissues, and deliver drugs through built-in vessels to mimic real human responses. Long term, we aim to replace diseased organs with functional, patient-specific tissues.
We are based in Houston, TX, and the company would remain there after YC.
Houston puts us close to Rice University where our technology started and provides access to biomedical and industrial bio partners. We're rooted here and it's where our team and ecosystem are strongest.
21 respuestas más en la aplicación completa
están en la versión completa. Crea una cuenta gratuita para abrirla en YC Insights, junto a cada otro batch de YC.
Preguntas Frecuentes
¿Es esta la aplicación YC real de Volumetric?
No. Y Combinator mantiene privadas las aplicaciones enviadas. Esta es una reconstrucción: las preguntas reales del formulario de YC, respondidas a partir de los datos públicos de Volumetric (notas de lanzamiento, antecedentes de fundadores, descripción del producto). Muestra cómo una empresa como Volumetric se presentaría a YC, no el texto que enviaron.
¿En qué batch de YC estuvo Volumetric?
Volumetric formó parte del batch Winter 2020 de Y Combinator.
¿Quién fundó Volumetric?
Volumetric fue fundado por Jordan Miller, Bagrat Grigoryan.
¿A qué se dedica Volumetric?
Volumetric builds living multicellular tissues with a focus on the…
¿Cómo leo la aplicación completa reconstruida?
Crea una cuenta gratuita de Round Funded. La versión completa de 26 respuestas de la aplicación de Volumetric, y de cada otro batch de YC, está en YC Insights.
Más startups de YC como Volumetric
